PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0223F0050Fentanyl norfentanyl immunoassay reagents for — Alere San Diego, Inc

Alere San Diego, Inc holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). PoP ended May 30, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Rhco Pacific

Awarding office

Alere San Diego, Inc

Recipient

May 30, 2023

PoP end

$342K

Obligated

$342K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alere San Diego, Inc — $90

Contract facts

Federal

Contract numberW81K0223F0050

Also listed asW81K02-23-F-0050

Also listed asN6264523D5004-W81K0223F0050

AgencyW40m Rhco Pacific

Awarding officeW40m Rhco Pacific

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAlere San Diego, Inc

CAGE6W6P3

UEITWMQTHHN6HM5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264523D5004

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startApr 18, 2023

PoP end (current)May 30, 2023

Obligated$342K

Current value$342K

Potential value$342K

FENTANYL/NORFENTANYL IMMUNOASSAY REAGENTS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII is a federal award for W40m Rhco Pacific held by Alere San Diego, Inc. Estimated value $342K ($342K obligated). Current period of performance ends May 30, 2023. Place of performance: SAN DIEGO CA.

FENTANYL/NORFENTANYL IMMUNOASSAY REAGENTS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII

Recompete timing

Public

● Past PoP end (1180 days ago)

Current PoP ended May 30, 2023 (1180 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alere San Diego, Inc — $42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 3 shown (3%); remaining ~97% is other agencies.

Department of Defense (DOD)$770K · 2%

Court Services and Offender Supervision Agency (CSOSA)$625K · 1%

Department of Transportation (DOT)$51K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W81K0223F0050?

W81K0223F0050 (Fentanyl norfentanyl immunoassay reagents for) is a W40m Rhco Pacific award with a potential value of $342K, currently held by Alere San Diego, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K02-23-F-0050?

W81K02-23-F-0050 is the dashed form of PIID W81K0223F0050 (Fentanyl norfentanyl immunoassay reagents for), held by Alere San Diego, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0223F0050?

W40m Rhco Pacific awarded W81K0223F0050 to Alere San Diego, Inc (potential $342K).

Who is the incumbent on W81K0223F0050?

Alere San Diego, Inc is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends May 30, 2023.

When does Alere San Diego, Inc’s W81K0223F0050 come up for recompete?

SCOUT tracks a period-of-performance end of May 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 17, 2023